drugset / Trial / NCT01280409

Metformin Postpartum for GDM RCT for Reduced Weight Retention

NCT01280409 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and whether there are any increased risks of side effects to you as a new mother.

Timeline

Start
2011-01
Primary completion
2014-03
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral

Indications